US Stock MarketDetailed Quotes

SXTP 60 Degrees Pharmaceuticals

Watchlist
  • 0.232
  • -0.039-14.39%
Trading Jul 22 10:59 ET
2.83MMarket Cap-2697P/E (TTM)

60 Degrees Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

60 Degrees Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 242.000K--
--2024/Q2-- / 211.500K--
--2024/Q1116.460K / 150.000K--
--2023/Q4125.680K / 100.000K--
--2023/Q3126.750K / 100.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 242.000K--
--2024/Q2-- / 211.500K--
--2024/Q1116.460K / 150.000K--
--2023/Q4125.680K / 100.000K--
--2023/Q3126.750K / 100.000K--

Unlock Free Earnings Estimates

60 Degrees Pharmaceuticals Earnings Reports

  • 10-Q: Quarterly report

    May 15 12:00 ET

  • 60 Degrees Pharmaceuticals | 10-K: Annual report

    Apr 1 14:37 ET

  • 60 Degrees Pharmaceuticals: Q3 2023 Earnings Report

    Nov 20, 2023 12:41 ET

  • 60 Degrees Pharmaceuticals | 10-Q: Quarterly report

    Aug 25, 2023 15:26 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-0.69%